PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $116,000 | -7.2% | 190,991 | 0.0% | 0.00% | – |
| Q1 2017 | $125,000 | +111.9% | 190,991 | 0.0% | 0.00% | – |
| Q4 2016 | $59,000 | -28.0% | 190,991 | 0.0% | 0.00% | – |
| Q3 2016 | $82,000 | +17.1% | 190,991 | 0.0% | 0.00% | – |
| Q2 2016 | $70,000 | -12.5% | 190,991 | 0.0% | 0.00% | – |
| Q1 2016 | $80,000 | -64.1% | 190,991 | 0.0% | 0.00% | – |
| Q4 2015 | $223,000 | +14.4% | 190,991 | 0.0% | 0.00% | – |
| Q3 2015 | $195,000 | -47.0% | 190,991 | -32.1% | 0.00% | -100.0% |
| Q2 2015 | $368,000 | -3.2% | 281,291 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $380,000 | -2.8% | 281,291 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $391,000 | +2.1% | 281,291 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $383,000 | -27.6% | 281,291 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $529,000 | -0.9% | 281,291 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $534,000 | +36.6% | 281,291 | 0.0% | 0.00% | +100.0% |
| Q4 2013 | $391,000 | +0.8% | 281,291 | +2.3% | 0.00% | 0.0% |
| Q3 2013 | $388,000 | -5.8% | 274,839 | -13.9% | 0.00% | 0.0% |
| Q2 2013 | $412,000 | – | 319,239 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 245,000 | $287,000 | 0.41% |
| Iguana Healthcare Management, LLC | 500,000 | $585,000 | 0.19% |
| Sterling Global Strategies LLC | 10,000 | $12,000 | 0.19% |
| Delaney Dennis R | 60,000 | $70,000 | 0.16% |
| Freedom Investment Management, Inc. | 816,347 | $955,000 | 0.07% |
| BAXTER BROS INC | 135,506 | $159,000 | 0.06% |
| First Heartland Consultants, Inc. | 86,204 | $101,000 | 0.04% |
| TWO SIGMA SECURITIES, LLC | 16,191 | $19,000 | 0.02% |
| CORRADO ADVISORS, LLC | 15,000 | $18,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 368,830 | $432,000 | 0.01% |